Document Detail

Microembolus detection by transcranial Doppler sonography: review of the literature.
Jump to Full Text
MedLine Citation:
PMID:  22195291     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Transcranial Doppler can detect microembolic signals which are characterized by unidirectional high intensity increase, short duration, random occurrence, and a "whistling" sound. Microembolic signals have been detected in a number of clinical settings: carotid artery stenosis, aortic arch plaques, atrial fibrillation, myocardial infarction, prosthetic heart valves, patent foramen ovale, valvular stenosis, during invasive procedures (angiography, percutaneous transluminal angioplasty), surgery (carotid, cardiopulmonary bypass, orthopedic), and in certain systemic diseases. Microembolic signals are frequent in large artery disease, less commonly detected in cardioembolic stroke, and infrequent in lacunar stroke. This article provides an overview about the current state of technical and clinical aspects of microembolus detection.
Authors:
Vlasta Vuković-Cvetković
Publication Detail:
Type:  Journal Article     Date:  2011-11-30
Journal Detail:
Title:  Stroke research and treatment     Volume:  2012     ISSN:  2042-0056     ISO Abbreviation:  Stroke Res Treat     Publication Date:  2012  
Date Detail:
Created Date:  2011-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101529024     Medline TA:  Stroke Res Treat     Country:  United States    
Other Details:
Languages:  eng     Pagination:  382361     Citation Subset:  -    
Affiliation:
Department of Neurology, University Hospital Center "Sestre milosrdnice," 10000, Zagreb, Croatia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Stroke Res Treat
Journal ID (publisher-id): SRT
ISSN: 2090-8105
ISSN: 2042-0056
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2012 Vlasta Vuković-Cvetković.
open-access:
Received Day: 1 Month: 8 Year: 2011
Accepted Day: 17 Month: 10 Year: 2011
Print publication date: Year: 2012
Electronic publication date: Day: 30 Month: 11 Year: 2011
Volume: 2012E-location ID: 382361
ID: 3236352
PubMed Id: 22195291
DOI: 10.1155/2012/382361

Microembolus Detection by Transcranial Doppler Sonography: Review of the Literature
Vlasta Vuković-Cvetković*
Department of Neurology, University Hospital Center “Sestre milosrdnice,” 10000, Zagreb, Croatia
Correspondence: *Vlasta Vuković-Cvetković: vlasta.vukovic@uclmail.net
[other] Academic Editor: Arijana Lovrencic-Huzjan

1. Introduction
1.1. Clinical Aspects

Acute stroke is one of the leading cause of morbidity and mortality worldwide. In developed countries, stroke ranks as either second or third most common cause of death and embolization is the cause of ischemic stroke in 40%–80% of cases [1]. TCD is a sensitive technique for real-time detection of microembolic signals (MESs). In the last 20 years, a substantial number of studies dealing with emboli detection have been carried out, showing that MES are proven to represent emboli passing within cerebral circulation. MES have been detected in a number of clinical conditions: carotid artery stenosis, aortic arch plaques, atrial fibrillation, myocardial infarction, prosthetic heart valves, patent foramen ovale, valvular stenosis, during carotid surgery, surgery on open heart, stent implantation, percutaneous transluminal angioplasty and angiography, and in patients with migraine and patent foramen ovale (PFO). Patients who have detectable MES, especially in larger number, should be considered as high-risk patients for stroke. MES detection may help in localization of embolic source, identification of patients with high stroke risk, monitoring during invasive procedures and surgery, and monitoring of the effectiveness of therapy.

Consensus on MES detection by TCD has been established [2]; MES can be identified as short lasting (<0.01–0.03 s), unidirectional intensity increase, and intensity increase (>3 dB) within the Doppler frequency spectrum; intensity increase is focused around 1 frequency. MESs appear randomly within the cardiac cycle and produce a “whistle,” “chirping,” or “clicking” sound when passing through the sample volume.

1.2. Technical Aspects

TCD is a very convenient tool to monitor intracranial circulation, however, the thick temporal bone window is an obstacle in certain patients. A new transcranial modality, power M-mode Doppler (PMD), has been developed to overcome the difficulties in location and insonation through transcranial ultrasound windows. PMD has 33 sample gates placed with 2 mm spacing for display of Doppler signal power, colored red and blue for directionality, in an M-mode format. The spectrogram from a user-selected depth is displayed simultaneously. PMD facilities window location and alignment of the ultrasound beam to view blood flow from multiple vessels simultaneously, without sound or spectral clues. MES appear as characteristic sloping high-power tracks in the PMD image [3, 4].

The optimal time of monitoring depends on the clinical entity. In patients with implanted artificial heart valves in whom MES can be detected in large proportion, monitoring during 30 minutes will be sufficient. In patients with carotid artery stenosis, atrial fibrillation, or other cardiac disease, frequency of MES is usually low, 1-2 MES over 60 minutes. Extended monitoring up to 8 hours, or repetitive monitoring over a couple of days in succession, is in relation with the percentage of MES positive patients [5, 6]. The embolic activity is highest in the first couple of hours after stroke; however, MES may be detectable days and weeks after cerebrovascular incidents which means that those patients are under higher risk for stroke [711].

Although technological improvement in the area of MES detection has recently developed, it is still impossible to reliably distinguish the composition of emboli (particles of fat, platelet aggregates, or particles of atheroma). Differentiation between solid and gaseous microemboli is based on the principle that solid emboli reflect more ultrasound at higher frequency, whereas the opposite is the case for gaseous emboli. This principle is used in multifrequency TCD instrumentation where the vessels are insonated simultaneously with 2.5 and 2.0 MHz and can be used for the differentiation between gaseous and solid emboli [12]. A recent study has shown that there is a significant relationship between low- and high-intensity MES, indicating that many MESs routinely rejected because of their low intensity are real and may predict future occurrence of high-intensity MES [13].


2. Clinical Condition in Which MES May Be Detected
2.1. Atherosclerotic Disease
2.1.1. Carotid Stenosis

Carotid artery stenosis is a well-known source of cerebral MES [7, 8, 1419]. Systematic review of the literature showed that MES can be detected in 43% of patients with symptomatic and in 10% with asymptomatic carotid stenosis; presence of one MES indicated an increased risk of future events (OR 7.5, 95% confidence interval (CI): 3.6–15.4, P < 0.0001 for symptomatic and OR 13.4, 95% CI: 6.5–27.4, P < 0.0001 for asymptomatic disease) [20]. A meta-analysis of the literature revealed that MESs are most frequent in large artery disease, less frequent in cardioembolic stroke, and infrequent in lacunar stroke. For symptomatic carotid stenosis, ES predicted stroke alone (OR, 9.57; P = 0.02) and stroke/TIA (OR, 6.36; P < 0.00001). For asymptomatic carotid stenosis, ES predicted stroke alone (OR, 7.46; P = 0.001) and stroke/TIA (OR, 12.00; P = 0.002) but with heterogeneity (P = 0.004). In acute stroke, ES predicted stroke alone (OR, 2.44; P = 0.02) and stroke/TIA (OR, 3.71; P = 0.002). A high frequency of ES immediately after carotid endarterectomy predicted stroke alone (OR, 24.54; P < 0.00001) and stroke/TIA (OR, 32.04; P < 0.00001). The meta-analysis suggests that MES predict stroke risk in acute stroke, symptomatic carotid stenosis, and postoperatively after carotid endarterectomy; however, in asymptomatic carotid stenosis, the predictive value of MES is less clear [21].

In the asymptomatic carotid emboli study (ACES), a prospective observational study, patients with asymptomatic carotid stenosis of at least 70% were monitored by TCD; the results showed that the hazard ratio for the risk of ipsilateral stroke and transient ischaemic attack from baseline to 2 years in patients with MES compared with those without was 2.54 (95% CI 1.20–5.36; P = 0.015). For ipsilateral stroke alone, the hazard ratio was 5.57 (1.61–19.32; P = 0.007). The absolute annual risk of ipsilateral stroke or transient ischaemic attack between baseline and 2 years was 7.13% in patients with MES and 3.04% in those without, and for ipsilateral stroke was 3.62% in patients with MES and 0.70% in those without [22].

Studies have shown that intraluminal thrombosis, irregular plaque surface, and ulceration are in relation with emboli frequency [2325]. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke [26].

Despite optimum standard antiplatelet therapy, cerebral microembolisation occurs in 30% of patients with symptomatic carotid artery disease [27]. Patients with symptomatic high-grade ICA stenosis and who were on antiplatelet treatment underwent bilateral MES monitoring for 30 minutes. The study has shown that the presence of MES is independent of intrastenotic blood flow disturbances and gray-scale ultrasound plaque characteristics. The authors concluded that the presence of MES is an indicator of an unstable plaque [27].

Carotid plaques in patients with severe unilateral carotid restenosis at least one year after surgery are similar to patients with primary severe stenosis in their embolic potential and ultrasonic characteristics [28].

Dissection of carotid arteries is an embolic source and MES in those patients can be detected in a high proportion [29]. Among patients with cervical artery dissection presenting with TIA or stroke, 50% had MES compared with 13% of patients with local symptoms (P = 0.006) [20].

2.1.2. Aortic Arch Atheroma

Aortic arch atheroma has long been underestimated as an embolic source. Studies have shown that severe atheroma of the aortic arch has now been established as an important and independent risk factor for stroke. The prevalence of severe arch atheroma among patients presenting with acute ischaemic stroke is approximately 20%.

The odds ratio for stroke or peripheral embolism in patients with severe arch atheroma (>4 mm) is greater than four, and for mobile atheroma it is greater than twelve, particularly in patients with other stroke risk factors. Patients found to have severe atheroma are at high risk of recurrent events (14.2% per year) and may, therefore, need an aggressive secondary prevention strategy [19, 20].

2.1.3. Intracranial Stenosis

Intracranial stenosis is a significant source of cerebral emboli, although in most studies not appreciated as important as carotid stenosis. A recent study has shown that MESs were reported in 25% of 220 patients with symptomatic versus 0% of 86 patients with asymptomatic intracranial stenosis (P < 0.0001) [20].

2.1.4. Thrombolysis and MES Occurrence

Thrombolysis is a well-established therapy in acute stroke. TCD has proven to serve as an enhancement tool in clot dissolution. MES detected by TCD at the site of arterial obstruction can indicate clot dissolution and recanalization of intracranial arteries, and therefore serve as a predictor for outcome [30].

2.1.5. Carotid Endarterectomy (CEA), Carotid Artery Stenting (CAS), and Percutaneous Transluminal Angioplasty (PTA)

After carotid endarterectomy, MESs disappear or the frequency is significantly lower [31, 32]. However, patients with clinically significant postoperative microembolism have an approximately 15 times higher risk of ipsilateral stroke or TIA [33]. Efficacy of CEA largely depends on postoperative results, that is, perisurgical complications. Intraoperative monitoring of hemodynamic changes and detection of MES may significantly influence postsurgical outcome [34]. Different antiplatelet regimens (combination of dipyridamole, aspirin and clopidogrel) following CEA does not show a significant influence on postoperative TCD embolization [35]. However, administration of dual antiplatelet therapy (clopidogrel 75 mg plus aspirin 75 mg) prior to CEA reduces postoperative embolisation and thromboembolic events [36].

Meta-analysis of trials to date shows that symptomatic and asymptomatic CAS patients had significantly higher 30-day postprocedure incidence of death/stroke/MI when compared with CEA patients [37, 38].

Experimental studies have shown that during PTA, the majority of MESs are gaseous in origin, while MESs detected during balloon inflation are probably attributable to solid particles [39].

The use of cerebral protection devices appears to reduce thromboembolic complications during PTA and stenting. The combined stroke and death rate within 30 days in patients treated with cerebral protection devices was 1.8% compared with 5,5% in patients without [40].

2.1.6. Angiography

MESs detected during angiography are attributable to gas bubbles, contrast injection, clot formation in catheter, and disrupted atheromatous material [41, 42]. Magnetic resonance studies have shown increased number of brain parenchymal lesions after angiography, although the majority of patients had nor neurological deficit [43]. However, angiography of the aortic arch is associated with 1% risk for stroke with permanent deficit, and in 3% mild-to-moderate stroke or TIA [41, 42]. In a study with 24 patients undergoing angiography, all had detectable MES, approximately 51 per patient. The majority of MES had the characteristics of gas bubbles. The number of detected MESs correlated with the volume of injected contrast and all patients except one who had stroke were asymptomatic [42].

2.2. Cardiac Sources

Approximately 15–30% of strokes are caused by cardiac diseases [44]. Prospective studies have shown that recurrent stroke or systemic embolization in that group of patients is high, approximately 20% [7, 45].

2.2.1. Atrial Fibrillation

Atrial fibrillation (AF) is present in 1,7% of population aged 60–64 years, and in 6% of population older than 75 years [46]. Incidence of stroke in patients with AF is 4,5% per year [47]. In cases when AF is associated with mitral valve stenosis, risk of stroke is 17 times higher [48]. Majority of strokes in patients with AF are embolic in origin; MES can be detected in 15–30% [49, 50].

2.2.2. Patent Foramen Ovale

The prevalence of patent foramen ovale (PFO) in common population is 22–34.4% [51, 52]. In patients with cryptogenic stroke, especially younger patients, a high prevalence of PFO has been found [53, 54]. The rate of recurrent stroke or TIA is 9.9% [55]. A multicentric study has shown that stroke risk over 4 years is 5,6% in patients with isolated PFO and 19,2% in patients with PFO and atrial septal aneurysm (ASA) [56]. However, a prospective population-based study has established that PFO is not an independent risk factor for stroke when age and comorbiditiy are considered [57].

A connection between migraine (especially migraine with aura), stroke, and PFO has been established [5863]. Studies have shown that the prevalence of PFO in patients with migraine is about 2.5 times greater in comparison with patients who do not suffer from migraine [64, 65]. Patients with migraine with aura have twice as high risk for stroke. Patients with probable migraine are 1, 5 times higher risk. If female patients with migraine smoke and take oral contraceptives, the risk increases up to seven times compared to those who do not have migraine [6668].

According to one of the proposed hypothesis, paradoxal embolization causes segmental hypoperfusion and vasodilatation, that is, PFO enables vasoactive substances (hypotheticaly serotonin) and microemboli from venous circulation to pass the pulmonal filter (normally they would be stopped in lungs), and entering the brain they can induce cortical spreading depression which characterizes migrainous attack [69]. This hypothesis could explain the decrease of migraine prevalence and intensity after PFO closure (in most studies). In favor of microembolization as a provoking factor speaks the MRI study in which a 13.7 times higher incidence of white matter lesions has been found in patients with migraine with aura compared to brains of controls [7072]. Furthermore, most TCD studies have shown that most paradoxical MES can be detected in posterior brain circulation [70], which is interesting because in these patients PFO and migraine are more frequently present. However, up to now, there is no definite evidence for proposed theories regarding migraine onset caused by circulating microemboli.

2.2.3. Prosthetic Heart Valves

Thromboembolism is a significant complication in patients with prosthetic heart valves (PHV). MES can be detectable in cerebral circulation ranging from 50 to 90% [7375]. The majority of HITS in patients with PHV correspond to gaseous, for example, due to cavitations at mechanical heart valves [76].

2.2.4. Myocardial Infarction

Approximately 2.5% of patients with acute myocardial infarction (MI) will have stroke within 2–4 months [77]. In a prospective study in patients with anterior wall MI, MES could be detected in 21% [78].

2.2.5. Infective Myocarditis

The prevalence of stroke in patients with infective myocarditis is 15–20% [79]. The size of vegetations has a predictive value: risk for embolization is higher in patients with vegetations larger than 10 mm, in patients with endocarditis of the mitral valve and mobile vegetations [79].

2.2.6. Dilatative Congestive Myocardiopathy

Incidence of embolic complications in patients with cardiomyopathy is 4% per year [78]. MESs are detectable in one third of patients with dilatative congestive myocardiopathy [44].

2.2.7. Mitral Valve Prolapse

Prevalence of mitral valve prolapse (MVP) in common population is 1–15% [80]. Isolated MVP is not considered as a significant risk factor for stroke in older patients, but in younger patients myxomatous change of mitral valves is considered to be in relationship with cerebrovascular incidents [80].

2.2.8. Cardiac Tumors

Although rare, atrial myxoma is the most frequent primary cardiac tumor, usually present in the left atrium. Due to its fragile nature, myxoma has a high potential for embolization to the brain as well as to other organs [81].

2.2.9. Systemic Diseases

MESs in cerebral circulation are detectable in primary antiphospholipid syndrome, Sneddon's syndrome, systemic lupus, Behcet's disease, and Takayasu's arteritis and are in temporal relation with cerebrovascular incidents in those patients [8285].

2.2.10. Coagulation

Clinical studies have shown that hyperfibrinogenemia is in a positive correlation with cardiovascular and cerebrovascular diseases [8688]. Patients with progressive atherosclerosis have higher levels of fibrinogen compared with those with nonprogressive disease [89].


3. Monitoring of Therapeutic Efficacy

Monitoring of therapeutic effect has shown that after CEA, MESs disappear or decrease in frequency, this finding is consistent through studies [31, 32]. Studies that investigated the efficacy of anticoagulant and antiaggregation therapy and frequency of MES have shown various results. Although some studies have shown decrease in MES frequency after aspirin or heparin administration, consistent correlation has not been found [90].

The first multicenter, randomized, double-blind trial that used MES detection as an endpoint to evaluate antiplatelet therapy, the Clopidogrel (CARESS and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis) trial, has shown that clopidogrel plus aspirin is superior to aspirin alone in reducing the frequency of MES in patients with recent symptomatic carotid stenosis [91]. Glycoprotein IIb/IIIa receptor antagonist tirofiban is a highly selective platelet aggregation inhibitor. Administration of tirofiban resulted in microembolic rate drop down to zero in patients with severe carotid artery stenosis in two studies. However, the inhibitory effect of tirofiban is reversible [92, 93].


4. Clinical Significance of Emboli Detection

It is important to emphasize that the vast majority of MESs do not produce immediate symptoms. MESs in cerebral circulation indicate asymptomatic patients with increased stroke risk. Nevertheless, correlation of cerebral microemboli with clinical symptoms (stroke or TIA ipsilateral to carotid stenosis, higher incidence of stroke in patients with cardiac diseases, neurological complications after angiography, postoperative neurological complications after CEA, in patients after CABG) in a number of studies has been shown. In symptomatic patients, the etiology of neurological deficit may be elucidated and adequate therapy may be introduced.

Patients with cerebral microembolism have higher cognitive deficits; cumulative effect of embolism is thought to be the cause. Even minor neuropsychological impairment should not be underestimated, the presence of an embolic source should be regarded as the possible cause for cognitive decline. Imaging techniques (CT scan, MRI, DWI-MRI) can show “silent” areas of cerebral ischemia. These small and multiple areas of acute or subacute brain infarction may occasionally present with clinical features atypical for brain embolism or will not produce any apparent symptoms [94].

Despite disputable clinical significance in certain conditions, the potential benefit of TCD detection of MES remains substantial.


References
1. Bogousslavsky J,Cachin C,Regli F,Despland PA,Van Melle G,Kappenberger L. Cardiac sources of embolism and cerebral infarction—clinical consequences and vascular concomitants: the Lausanne Stroke RegistryNeurologyYear: 19914168558592046930
2. Ringelstein RB,Droste DW,Babikian VI,et al. Consensus on microembolus detection by TCD: international consensus group on microembolus detectionStrokeYear: 19982937257299506619
3. Moehring MA,Spencer MP. Power M-mode Doppler (PMD) for observing cerebral blood flow and tracking emboliUltrasound in Medicine and BiologyYear: 2002281495711879952
4. Choi Y,Saqqur M,Asil T,et al. A combined power M-mode and single gate transcranial doppler ultrasound microemboli signal criteria for improving emboli detection and reliabilityJournal of NeuroimagingYear: 201020435936719912481
5. Droste DW,Ritter M,Kemeny V,Schulte-Altedorneburg G,Ringelstein BE. Microembolus detections at follow-up in 19 patients with acute stroke. Correlation with stroke etiology and antithrombotic treatmentCerebrovascular DiseasesYear: 200010427227710878431
6. Molloy J,Khan N,Markus HS. Temporal variability of asymptomatic embolization in carotid artery stenosis and optimal recording protocolsStrokeYear: 1998296112911329626283
7. Sliwka U,Lingnau A,Stohlmann WD,et al. Prevalence and time course of microembolic signals in patients with acute strokeStrokeYear: 19972823583639040690
8. Forteza AM,Babikian VL,Hyde C,Winter M,Pochay V. Effect of time and cerebrovascular symptoms on the prevalence of microembolic signals in patients with cervical carotid stenosisStrokeYear: 19962746876908614931
9. Demarin V,Rundek T,Vuković V. Klingerhoefer JPrevalence of cerebral emboli in patients with carotid artery diseaseNew Trends in Cerebral Hemodynamics and NeurosonologyYear: 1997Elsevier Science B.V.420444
10. Marcus HS,Thompson N,Droste DW,et al. Cerebral embolic signals in carotid artery stenosis and their temporal variabilityCerebrovascular DiseasesYear: 19944, article 22
11. van Zuilen EV,Mauser HW,van Gijn J,et al. The relationship between cerebral microemboli and symptomatic cerebral ischaemia: a study of transcranial Doppler monitoringCerebrovascular DiseasesYear: 19944, article 20
12. Russell D,Brucher R. Embolus detection and differentiation using multifrequency transcranial DopplerStrokeYear: 200536, article 706
13. Telman G,Sprecher E,Kouperberg E. Potential relevance of low-intensity microembolic signals by TCD monitoringNeurological SciencesYear: 20113210711120953814
14. Ries S,Schminke U,Daffertshofer M,Schinlmayr C,Hennerici M. High intensity transient signals and carotid artery diseaseCerebrovascular DiseasesYear: 19955124127
15. Eicke BM,von Lorentz J,Paulus W. Embolus detection in different degrees of carotid diseaseNeurological ResearchYear: 19951731811847643973
16. Hutchinson S,Riding G,Coull S,McCollum CN. Are spontaneous cerebral microemboli consistent in carotid disease?StrokeYear: 200233368568811872888
17. Molloy J,Markus HS. Asymptomatic embolization predicts stroke and TIA risk in patients with carotid artery stenosisStrokeYear: 19993071440144310390320
18. Vassileva E,Schnorf H,Personeni O,Floch-Rohr J. Microembolic signals and early recurrent cerebral ischemia in carotid artery diseaseStrokeYear: 19993014901493
19. Viguier A,Pavy le Traon A,Massabuau P,Valton L,Larrue V. Asymptomatic cerebral embolic signals in patients with acute cerebral ischaemia and severe aortic arch atherosclerosis.Journal of NeurologyYear: 2001248976877111596781
20. Ritter MA,Dittrich R,Thoenissen N,Ringelstein EB,Nabavi DG. Prevalence and prognostic impact of microembolic signals in arterial sources of embolism: a systematic review of the literatureJournal of NeurologyYear: 2008255795396118458865
21. King A,Markus HS. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysisStrokeYear: 200940123711371719850894
22. Markus HS,King A,Shipley M,et al. Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational studyThe Lancet NeurologyYear: 201097663671
23. Sitzer M,Muller W,Siebler M,et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosisStrokeYear: 1995267123112337604420
24. Siebler M,Kleinschmidt A,Sitzer M,Steinmetz H,Freund HJ. Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosisNeurologyYear: 19944446156187909360
25. Zhang C,Qu S,Li H,et al. Microembolic signals and carotid plaque characteristics in patients with asymptomatic carotid stenosisScandinavian Cardiovascular JournalYear: 200943534535119863395
26. Moustafa RR,Izquierdo-Garcia D,Fryer TD,et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot studyCirculationYear: 20103553654120639303
27. Zuromskis T,Wetterholm R,Lindqvist JF,et al. Prevalence of micro-emboli in symptomatic high grade carotid artery disease: a transcranial Doppler studyEuropean Journal of Vascular and Endovascular SurgeryYear: 200835553454018291690
28. Telman G,Kouperberg E,Hlebtovsky A,et al. Embolic potential and ultrasonic characteristics of plaques in patients with severe unilateral carotid restenosis more than one year after surgeryJournal of the Neurological SciencesYear: 20092851-2858719501842
29. Molina CA,Alvarez-Sabín J,Schonewille W,et al. Cerebral microembolism in acute spontaneous internal carotid artery dissectionNeurologyYear: 200055111738174011113235
30. Alexandrov AV,Demchuk AM,Felberg RA,Grotta JC,Krieger DW. Intracranial clot dissolution is associated with embolic signals on transcranial DopplerJournal of NeuroimagingYear: 2000101273210666979
31. Siebler M,Sitzer M,Rose G,Bendfeldt D,Steinmetz H. Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis. Event rates before and after carotid endarterectomyBrainYear: 19931165100510158221045
32. van Zuilen EV,Moll FL,Vermeulen FEE,Mauser HW,van Gijn J,Ackerstaff RGA. Detection of cerebral microemboli by means of transcranial Doppler monitoring before and after carotid endarterectomyStrokeYear: 19952622102137831689
33. Abbott AL,Levi CR,Stork JL,Donnan GA,Chambers BR. Timing of clinically significant microembolism after carotid endarterectomyCerebrovascular DiseasesYear: 2007235-636236717268167
34. Lennard N,Smith J,Dumville J,et al. Prevention of postoperative thrombotic stroke after carotid endarterectomy: the role of transcranial Doppler ultrasoundJournal of Vascular SurgeryYear: 19972645795849357457
35. de Borst GJ,Hilgevoord AAJ,de Vries JPPM,et al. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoringEuropean Journal of Vascular and Endovascular SurgeryYear: 200734213514217521930
36. Sharpe RY,Dennis MJS,Nasim A,et al. Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial doppler monitoring is now unnecessaryEuropean Journal of Vascular and Endovascular SurgeryYear: 201040216216720451426
37. Sidawy AN,Zwolak RM,White RA,Siami FS,Schermerhorn ML,Sicard GA. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular RegistryJournal of Vascular SurgeryYear: 2009491717919028045
38. Brahmanandam S,Ding EL,Conte MS,Belkin M,Nguyen LL. Clinical results of carotid artery stenting compared with carotid endarterectomyJournal of Vascular SurgeryYear: 200847234334918241758
39. Markus HS,Brown MM. Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro modelStrokeYear: 1993241158418529
40. Kastrup A,Gröschel K,Krapf H,Brehm BR,Dichgans J,Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literatureStrokeYear: 200334381381912624315
41. Gerraty RP,Bowser DN,Infeld B,Mitchell PJ,Davis SM. Microemboli during carotid angiography: association with stroke risk factors or subsequent magnetic resonance imaging changes?StrokeYear: 1996279154315478784127
42. Bendszus M,Koltzenburg M,Burger R,Warmuth-Metz M,Hofmann E,Solymosi L. Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective studyThe LancetYear: 1999354919015941597
43. Gerraty RP,Bowser DN,Infeld B,Mitchell PJ,Davis SM. Microemboli during carotid angiography: association with stroke risk factors or subsequent magnetic resonance imaging changes?StrokeYear: 1996279154315478784127
44. Sliwka U,Job F-P,Wissuwa D,et al. Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism: a prospective studyStrokeYear: 19952611206720707482651
45. Yasaka M,Yamaguchi T,Oita J,Sawada T,Shichiri M,Omae T. Clinical features of recurrent embolization in acute cardioembolic strokeStrokeYear: 19932411168116858236343
46. Lake FR,Cullen KJ,De Klerk NH,McCall MG,Rosman DL. Atrial fibrillation and mortality in an elderly populationAustralian and New Zealand Journal of MedicineYear: 19891943213262789508
47. Wolf PA,Abbott RD,Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham studyStrokeYear: 19912289839881866765
48. Lin HJ,Wolf PA,Kelly-Hayes M,et al. Stroke severity in atrial fibrillation: the Framingham studyStrokeYear: 19962710176017648841325
49. Cullinane M,Wainwright R,Brown A,Monaghan M,Markus HS. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective studyStrokeYear: 1998299181018159731600
50. Rundek T,Demarin V,Vuković V,Podobnik-Šarkanji S,Starčević B. Klingerhoefer JTCD detection of cerebral emboli in patients with nonvalvular atrial fibrillation: a 1 year follow-up surveyNew Trends in Cerebral Hemodynamics and NeurosonologyYear: 1997Elsevier Science B.V.435440
51. Konstadt SN,Louie EK,Black S,Rao TLK,Scanlon P. Intraoperative detection of patent foramen ovale by transesophageal echocardiographyAnesthesiologyYear: 19917422122161990894
52. Hagen PT,Scholz DG,Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal heartsMayo Clinic ProceedingsYear: 198459117206694427
53. Lechat P,Mas JL,Lascault G,et al. Prevalence of patent foramen ovale in patients with strokeThe New England Journal of MedicineYear: 198831818114811523362165
54. Jeanrenaud X,Bogousslavsky J,Payot M,Regli F,Kappenberger L. Patent foramen ovale and cerebral infarct in young patientsSchweiz Med WochenschrYear: 19901208238292360007
55. Nedeltchev K,Arnold M,Wahl A,et al. Outcome of patients with cryptogenic stroke and patent foramen ovaleJournal of Neurology Neurosurgery and PsychiatryYear: 2002723347350
56. Mas J-L,Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal AneurysmAmerican Heart JournalYear: 19951305108310887484740
57. Stratton JR,Resnick AD. Increased embolic risk in patients with left ventricular thrombiCirculationYear: 1987755100410113568301
58. Piechowski-Jozwiak B,Devuyst G,Bogousslavsky J. Migraine and patent foramen ovale: a residual coincidence or a pathophysiological intrigue?Cerebrovascular DiseasesYear: 2006222-39110016685120
59. Schwedt TJ,Dodick DW. Patent foramen ovale and migraine - Bringing closure to the subjectHeadacheYear: 200646466367116643562
60. Spies C,Kavinsky CJ,Schräder R. Patent foramen ovale in patients with migraine headache. Should it be closed?Minerva MedicaYear: 2007981253617372579
61. Wammes-van der Heijden EA,Tijssen CC,Egberts ACG. Right-to-left shunt and migraine: the strength of the relationshipCephalalgiaYear: 200626220821316426277
62. Carolei A,Marini C,De Matteis G,the Italian National Reasearch Council Study Group on Stroke in the Young. History of migraine and risk of cerebral ischaemia in young adults The LancetYear: 1996347901415031506
63. Ries S,Steinke W,Neff W,Schindlmayr C,Meairs S,Hennerici M. Ischemia-induced migraine from paradoxical cardioembolic strokeEuropean NeurologyYear: 199636276788654489
64. Del Sette M,Angeli S,Leandri M,et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control studyCerebrovascular DiseasesYear: 1998863273309774749
65. Anzola GP,Magoni M,Guindani M,Rozzini L,Volta GD. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler studyNeurologyYear: 19995281622162510331688
66. Wingerchuk DM,Spencer B,Dodick DW,Demaerschalk BM. Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topicNeurologistYear: 200713423123317622918
67. Becker C,Brobert GP,Almqvist PM,Johansson S,Jick SS,Meier CR. Migraine and the risk of stroke, TIA, or deathin the UK (CME)HeadacheYear: 200747101374138418052947
68. MacClellan LR,Giles W,Cole J,et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women studyStrokeYear: 20073892438244517690308
69. Wilmshurst PT,Nightingale S,Walsh KP,Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasonsThe LancetYear: 2000356924216481651
70. Venketasubramanian N,Sacco RL,Di Tullio M,Sherman D,Homma S,Mohr JP. Vascular distribution of paradoxical emboli by transcranial DopplerNeurologyYear: 1993438153315358351007
71. Kruit MC,van Buchem MA,Hofman PAM,et al. Migraine as a risk factor for subclinical brain lesionsJAMAYear: 2004291442743414747499
72. Rocca MA,Colombo B,Inglese M,Codella M,Comi G,Filippi M. A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraineJournal of Neurology Neurosurgery and PsychiatryYear: 2003744501503
73. Müller HR,Burckhardt D,Casty M,Pfisterer ME,Buser MW. High intensity transcranial Doppler signals (HITS) after prosthetic valve implantationJournal of Heart Valve DiseaseYear: 1994366026068000601
74. Markus HS,Droste DW,Brown MM. Detection of asymptomatic cerebral embolic signals with doppler ultrasoundThe LancetYear: 1994343890410111012
75. Braeken SK,Russell D,Brucher R,et al. Cerebral emboli in prosthetic heart valve patientsStrokeYear: 199425, article 739
76. Droste DW,Hansberg T,Kemény V,et al. Oxygen inhalation can differentiate gaseous from nongaseous microemboli detected by transcranial Doppler ultrasoundStrokeYear: 19972812245324569412631
77. Manning WJ. Role of transesophageal echocardiography in the management of thromboembolic strokeAmerican Journal of CardiologyYear: 1997804, supplement 319D28D
78. Cerebral Embolism Task ForceCardiogenic brain embolism. The second report of the Cerebral Embolism Task ForceArchives of NeurologyYear: 19894677277432662950
79. Freedberg RS,Goodkin GM,Perez JL,Tunick PA,Kronzon I. Valve strands are strongly associated with systemic embolization: a transesophageal echocardiographic studyJournal of the American College of CardiologyYear: 1995267170917127594107
80. Orencia AJ,Petty GW,Khandheria BK,et al. Risk of stroke with mitral valve prolapse in population-based cohort studyStrokeYear: 19952617137839400
81. Cerebral Embolism Task ForceCardiogenic brain embolism. The second report of the Cerebral Embolism Task ForceArchives of NeurologyYear: 19894677277432662950
82. Kumral E,Evyapan D,Aksu K,Keser G,Kabasakal Y,Balkir K. Microembolus detection in patients with Takayasu’s arteritisStrokeYear: 200233371271611872893
83. Sitzer M,Sohngen D,Siebler M,et al. Cerebral microembolism in patients with Sneddon’s syndromeArchives of NeurologyYear: 19955232712757872880
84. Specker C,Rademacher J,Söhngen D,et al. Cerebral microemboli in patients with antiphospholipid syndromeLupusYear: 1997686386449364422
85. Kumral E,Evyapan D,Oksel F,Keser G,Bereketoğlu MA,Balkir K. Transcranial doppler detection of microembolic signals in patients with Behcet’s diseaseJournal of NeurologyYear: 1999246759259510463362
86. Vuković V. Korelacija transkranijskog doplera s kliničkim statusom i parametrima koagulacije u otkrivanju moždanih embolusaMagistarski RadYear: 1997Zagreb, CroatiaMedicinski Fakultet, Sveučilište u Zagrebu
87. Resch KL,Ernst E,Matrai A,Paulsen HF. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivorsAnnals of Internal MedicineYear: 199211753713751503327
88. Heppell RM,Berkin KE,McLenachan JM,Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillationHeartYear: 19977754074119196408
89. Coull BM,Beamer N,de Garmo P,et al. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for strokeStrokeYear: 19912221621682003279
90. Goertler M,Baeumer M,Kross R,et al. Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acidStrokeYear: 199930166699880390
91. Markus HS,Droste DW,Kaps M,et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trialCirculationYear: 2005111172233224015851601
92. Junghans U,Siebler M. Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonistCirculationYear: 2003107212717272112742983
93. van Dellen D,Tiivas CAS,Jarvi K,Marshall C,Higman DJ,Imray CHE. Transcranial Doppler ultrasonography-directed intravenous glycoprotein IIb/IIIa receptor antagonist therapy to control transient cerebral microemboli before and after carotid endarterectomyBritish Journal of SurgeryYear: 200895670971318425794
94. Aly A,Babikian VL,Barest G,Artinian M,Forteza A,Kase CS. Brain microembolismJournal of NeuroimagingYear: 200313214014612722496

Article Categories:
  • Review Article


Previous Document:  A Parallel Thrombolysis Protocol with Nurse Practitioners As Coordinators Minimized Door-to-Needle T...
Next Document:  Development and Process Evaluation of a 5-Week Exercise Program to Prevent Falls in People after Str...